Magnus K. Magnusson is a physician-scientist and board certified hematologist. He is Professor of Pharmacology and Chair of the Department of Pharmacology & Toxicology, University of Iceland - Medical School. He is also consulting hematologist at the Department of Laboratory Hematology and Executive Chair of the Research Biobank of the Division of Laboratory Medicine at the University Hospital. He received his medical degree from the University of Iceland. After finishing his residency (Internal Medicine, Clinical Investigator Pathway) from the University of Wisconsin, Madison he did his clinical and research fellowship in hematology at the National Heart, Lung, and Blood Institute (NHLBI), Bethesda Maryland. During his medical studies and post-graduate training he has worked endothelial cell signalling with Dr. Gudmundur Thorgeirsson, the cell biology of extracellular matrix with Dr. Deane Mosher in Madison and later with Dr. Cynthia Dunbar at the NHLBI on the molecular and stem cell biology of leukemia
Research Engineer at the Molecular Biophysics platform (PFBMI) at the Institut Pasteur, Paris. He is in charge of the spectroscopic line with circular dichroism device, stationary phase and stopped-flow fluorimetry, thermophoresis. The responsibility includes the training of new users, the maintenance and know-how of material, the understanding of the technology allowing the monitoring of short, medium and long term interaction with researchers, beginners or experts who need to complete their studies by biophysical measurements.
Beata G. Vertessy Professor
Budapest University of Technology and Economics, Hungary
Beata G. Vertessy is currently appointed as group Leader (PI) Genome metabolism and Repair Laboratory, Institute of Enzymology, Hungarian Academy of Sciences. She has over 90 peer-reviewed articles in international peer-reviewed scientific journals. Two book chapters, six patent applications, >200 other publications, >50 invited talks at international conferences. Current areas of research: cellular trafficking, DNA repair, cell death pathways, cell biology, molecular and structural biology, molecular targets against tuberculosis and malaria
Hamutal Meiri holds a PhD in Neurobiology from the Hebrew University of Jerusalem (1979) and a MBA degree from Tel Aviv University, Recanati School of Business (1995). She was a faculty member in brain development in the medical schools of Tel Aviv University, Technion, and NYU (1982-1990), and a Visiting Professorship at Weil-Cornell Medical College, NY. In 1991 she was appointed to be the first Director of Israel National Committee of Biotech, and also served as the Research Advisor to UNESCO COBIOTECH Committee. In 1994-1999 she was the Consortium Director of Israel Chief Scientist Magnet program (Biotech). In 1996-1998 she was elected to be the Head of Israel Telemedicine Industry Forum, and also served as a consultant to the Scandinavians Prime Ministers on Telemedicine.